No photo of Maurizio Miglino

View Scopus Profile

Maurizio Miglino

1988 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maurizio Miglino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Cytarabine Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Idarubicin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia

Marcolin, R., Guolo, F., Minetto, P., Clavio, M., Manconi, L., Ballerini, F., Carli, A., Passannante, M., Colombo, N., Carminati, E., Pugliese, G., Tedone, E., Contini, P., Mangerini, R., Kunkl, A., Miglino, M., Cagnetta, A., Cea, M., Gobbi, M. & Lemoli, R. M., Nov 1 2019, In : Leukemia Research. 86, 106223.

Research output: Contribution to journal › Article

Acute Myeloid Leukemia
Mutation
HLA-DR Antigens
Karyotype
Multivariate Analysis

Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas

Manconi, L., Coviello, E., Canale, F., Giannoni, L., Minetto, P., Guolo, F., Clavio, M., Marcolin, R., Cea, M., Cagnetta, A., Gobbi, M., Miglino, M., Ballerini, F. & Lemoli, R. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journal › Article

oxaliplatin
Lymphoma, Large B-Cell, Diffuse
Cytarabine
Cell- and Tissue-Based Therapy
Dexamethasone

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis

Balleari, E., Filiberti, R. A., Salvetti, C., Allione, B., Angelucci, E., Bruzzone, M., Calzamiglia, T., Cavaliere, M., Cavalleri, M., Cilloni, D., Clavio, M., Crisà, E., Da Col, A., Danise, P., Pilo, F., Ferrero, D., Finelli, C., Gioia, D., Lemoli, R. M., Masiera, E. & 10 others, Messa, E., Miglino, M., Musto, P., Natalie Oliva, E., Poloni, A., Salvi, F., Sanna, A., Scudeletti, M., Tassara, R. & Santini, V., Jan 1 2019, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journal › Article

Open Access
Propensity Score
Myelodysplastic Syndromes
Erythropoietin
Survival
Leukemia

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis

Balleari, E., Filiberti, R. A., Salvetti, C., Allione, B., Angelucci, E., Bruzzone, M., Calzamiglia, T., Cavaliere, M., Cavalleri, M., Cilloni, D., Clavio, M., Crisà, E., Da Col, A., Danise, P., Pilo, F., Ferrero, D., Finelli, C., Gioia, D., Lemoli, R. M., Masiera, E. & 10 others, Messa, E., Miglino, M., Musto, P., Natalie Oliva, E., Poloni, A., Salvi, F., Sanna, A., Scudeletti, M., Tassara, R. & Santini, V., 2019, In : Cancer Medicine.

Research output: Contribution to journal › Article

Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach

Guolo, F., Minetto, P., Clavio, M., Miglino, M., Colombo, N., Cagnetta, A., Cea, M., Marcolin, R., Todiere, A., Ballerini, F., Gobbi, M. & Lemoli, R. M., Sep 1 2019, In : British Journal of Haematology. 186, 6, p. e223-e225

Research output: Contribution to journal › Letter